160 HEALTH (02656) has been included in the Hang Seng Composite Index and is expected to become a target for the Hong Kong stock connect.

On February 13, Hang Seng Index Company announced the results of the quarterly review of the Hang Seng Index Series until December 31, 2025, with 160 HEALTH (02656) being included in the Hang Seng Composite Index. The changes will be implemented after the close of trading on March 6, 2026 (Friday) and will take effect from March 9, 2026 (Monday), at which time the Shanghai and Shenzhen Stock Exchanges will adjust the scope of eligible investments for the Stock Connect. According to CICC research report, 160 HEALTH may be included in the Stock Connect as it meets a series of criteria including market capitalization, liquidity, and listing time. The prospectus shows that 160 HEALTH is an experienced wholesale distributor of health products and a leading digital healthcare comprehensive service provider under China Meheco Group. The company provides customers with various medical and health products, as well as comprehensive digital healthcare solutions. In addition, the company also provides digital healthcare solutions through its online healthcare platform - 160 HEALTH platform, empowering all participants in the entire healthcare industry chain. As of March 31, 2025, the platform of 160 HEALTH has connected over 44,600 medical and health institutions since its establishment.